Thierry Kalonji
Thierry Kalonji
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Emile Malembi
Emile Malembi
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Jean Paul Matela
Jean Paul Matela
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Toutou Likafi
Toutou Likafi
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Eddy Kinganda-Lusamaki
Eddy Kinganda-Lusamaki
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Emmanuel Hasivirwe Vakaniaki
Emmanuel Hasivirwe Vakaniaki
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Nicole A Hoff
Nicole A Hoff
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,✉,
Amuri Aziza
Amuri Aziza
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Francisca Muyembe
Francisca Muyembe
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Joelle Kabamba
Joelle Kabamba
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Tine Cooreman
Tine Cooreman
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Béatrice Nguete
Béatrice Nguete
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Danae Witte
Danae Witte
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Ahidjo Ayouba
Ahidjo Ayouba
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Nicolas Fernandez-Nuñez
Nicolas Fernandez-Nuñez
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Stijn Roge
Stijn Roge
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Martine Peeters
Martine Peeters
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Sydney Merritt
Sydney Merritt
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Steve Ahuka-Mundeke
Steve Ahuka-Mundeke
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Eric Delaporte
Eric Delaporte
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Elisabeth Pukuta
Elisabeth Pukuta
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Joachim Mariën
Joachim Mariën
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Eugene Bangwen
Eugene Bangwen
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Steven Lakin
Steven Lakin
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Charles Lewis
Charles Lewis
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Jeffrey B Doty
Jeffrey B Doty
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Laurens Liesenborghs
Laurens Liesenborghs
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Lisa E Hensley
Lisa E Hensley
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Andrea McCollum
Andrea McCollum
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Anne W Rimoin
Anne W Rimoin
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Jean Jacques Muyembe-Tamfum
Jean Jacques Muyembe-Tamfum
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Robert Shongo
Robert Shongo
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Didine Kaba
Didine Kaba
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12,
Placide Mbala-Kingebeni
Placide Mbala-Kingebeni
1Program National Lutte Contre MPX-VHF, Kinshasa, Democratic Republic of the Congo (T. Kalonji, E. Malembi, R. Shongo);
2Province Health Division, Tshuapa, Democratic Republic of the Congo (J.P. Matela, T. Likafi);
3Institute National de Recherche Biomedical, Kinshasa (E. Kinganda-Lusamaki, E.H. Vakaniaki, A. Aziza, F. Muyembe, S. Ahuka-Mundeke, E. Pukuta, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
4Cliniques Universitaires de Kinshasa, Kinshasa (E. Kinganda-Lusamaki, F. Muyembe, S. Ahuka-Mundeke, J.J. Muyembe-Tamfum, P. Mbala-Kingebeni);
5University of Montpellier, IRD, INSERM, Montpellier, France (E. Kinganda-Lusamaki, A. Ayouba, N. Fernandez-Nuñez, M. Peeters, E. Delaporte);
6University of California, Los Angeles, California, USA (N.A. Hoff, S. Merritt, A.W. Rimoin);
7Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Kabamba, J.B. Doty, A. McCollum);
8University of Antwerp, Antwerp, Belgium (T. Cooreman, J. Mariën);
9Kinshasa School of Public Health, Kinshasa (B. Nguete, D. Kaba);
10University of Florida, Gainesville, Florida, USA (D. Witte);
11Institute of Tropical Medicine, Antwerp (S. Roge, E. Bangwen, L. Liesenborghs);
12US Department of Agriculture, Manhattan, Kansas, USA (S. Lakin, C. Lewis, L.E. Hensley)
1,2,3,4,5,6,7,8,9,10,11,12